MARKET INFO
Pink Sheets: MDBX
Get a detailed quote for
MDBX
Shares Outstanding:
11,016,839 as of Dec 31, 2011
Authorized Shares:
100,000,000 as of Dec 31, 2011
Shareholders of Record:
63 as of Sep 30, 2011
Transfer Agent:
Action Stock Transfer Corporation
AUDIO INTERVIEWS
6/5/12
LATEST HEADLINES
Medbox Developing a Patent Pending Wall-Mounted Biometric Kiosk for Storage of Sensitive Medicine Samples and Supplies for Doctor's Offices
Medbox, Inc. Posts 1st Quarter 2012 Financials - Record Revenues Reported
KEY EXECUTIVES
Vincent Mehdizadeh
PVM Founder
Chief Executive Officer
Dr. Bruce Bedrick
Medbox President
Board Member
Chief Operations Officer of PVM
Leila Guieb
Medbox Treasurer
Board Member
Chief Financial Officer of PVM
Angelique Dolan
PVM Director of Marketing
|
MDBX is expanding their shareholder base for a limited time and offering considerable discounts on shares direct from the company to accredited investors.
PROFILE
The Medbox™ is a patented biometric medicine dispensing system that can dispense a wide variety of medicine and is sold to traditional pharmacies, doctors’ offices, hospitals, urgent care centers, and alternative medicine clinics. The Medbox stands independently, can be interfaced with a counter-top patient verification point-of-sale system, and has a refrigerated products dispensing option. It is manufactured under contract with minimal fixed investment and lower break-even costs.
We offer consulting services to individuals seeking to establish a new clinic. These are high margin services provided by the company’s key officers.
We generate revenue from maintenance contracts on installed machines and systems. Services are delivered through a third-party provider, thus minimizing the company’s investment in a service network.
We offer merchant credit card processing services to our clients through a third-party provider and earn a share of merchant fees earned.
The Company is NOT engaged in the manufacturing or distribution of any products sold through its machines or related equipment.
Value Proposition
- Company announced on 5/7/12 gross revenues and receivables generated of 1.45 million dollars for the quarter ending March 31 2012. This is the highest quarterly revenue and EBITDA in the company's history. Company has previously generated over 3.6 million dollars in revenue and retained over 1.4 million dollars in earnings within the last 2 quarters of 2010 and first 2 quarters of 2011.
- MDBX is well established in markets with high barriers to entry such as the medical marijuana market. The Company provides software and consulting that assists operators with efficiency and compliance in this evolving and explosive market.
- Patented dispensing system – U.S. Patent US 7,844,363 B1
- Multi-channel revenue stream. In addition to alternative and medical marijuana clinics, the patented dispensing system is effective in pharmacies, urgent care centers, and traditional doctor’s offices. Beyond the increased efficiency and compliance factors, the product protects its customers from employee and as well as outside theft.
- Product has been tested and has gained market acceptance.
- Through its consulting business, MDBX is first to market in many states with newly minted medical marijuana laws like Arizona and Connecticut. The Company assisted over 100 companies trying to obtain licenses for medical marijuana dispensaries in Arizona. MDBX then gets to sell those companies successful in obtaining a license their technology and services. As more states come to terms with medical marijuana MDBX is positioned for explosive growth.
- Unlike many other Micro Cap companies, MDBX has been around for 30 years and the new subsidiaries like Prescription Vending Machines, Inc. DBA Medicine Dispensing Systems were profitable and growing before being acquired.
- Executive Management Team Comprised of 2 MBAs, and 2 Doctorates
- Product featured in numerous media interviews - CNN – ABC News – Fox News – CNBC.
- Company has secured an endorsement for its technology in Colorado’s HB1043 medical marijuana bill enacted into law July 1, 2011.
- Competitors Quiqmeds and Instymeds are the only machines in production in the marketplace. These only focus on placement within doctor’s offices and not within pharmacies or alternative medicine clinics. Neither machine possesses biometrics nor a patient database that is present within PVM’s patent on its dispensing machine and software.
- Implementing a full-scale marketing and advertising program. Integrated campaign combining online and offline demand generation activities with emphasis on creating greater brand awareness. Establish brand as preeminent dispensing system by leveraging existing media coverage.
|
